Decoding genetic divergence: TPMT and NUDT15 polymorphisms in north India mirror Caucasian ancestry [0.03%]
解码遗传差异：北印度人群中的TPMT和NUDT15多态性反映高加索人祖先的影响
Arshdeep Singh,Renu Moti Pandita,Manjeet Kumar Goyal et al.
Arshdeep Singh et al.
Lifestyle restrictions are associated with impaired quality of life but not reduction in relapse in ulcerative colitis [0.03%]
生活方式限制与溃疡性结肠炎患者的生活质量下降有关，但与其病情缓解无关
Hajime Yamazaki,Masakazu Nagahori,Tadakazu Hisamatsu et al.
Hajime Yamazaki et al.
Background/aims: Patients with ulcerative colitis (UC) in remission commonly restrict thir lifestyle to prevent relapse; however, the effectiveness and impact on quality of life (QOL) is unclear. This study investigated w...
Response: Comments on "Adequacy of sigmoidoscopy as compared to colonoscopy for assessment of disease activity in patients of ulcerative colitis: a prospective study" [0.03%]
关于“评估溃疡性结肠炎患者疾病活动度时内镜检查充分性的前瞻性研究”的评论
Sameet Tariq Patel,Sanjay Chandnani,Pravin M Rathi
Sameet Tariq Patel
Does statin have a chemopreventive effect in patients with ulcerative colitis? [0.03%]
溃疡性结肠炎患者的他汀类药物化学预防作用探讨
Yoon Suk Jung
Yoon Suk Jung
Anti-integrin αvβ6 autoantibody in patients with ulcerative colitis after proctocolectomy: a cross-sectional study in Japan [0.03%]
日本溃疡性结肠炎患者的回肠肛门 pouch术后的抗αvβ6整合素自身抗体：横断面研究
Tsuyoshi Yanagida,Yu Nishida,Yumie Kobayashi et al.
Tsuyoshi Yanagida et al.
Background/aims: Pouchitis is a common complication in patients with ulcerative colitis (UC) following colectomy with ileal pouch-anal anastomosis (IPAA). Recent studies have identified a novel autoantibody against integr...
Gut, bone, and muscle: the triad of osteosarcopenia in inflammatory bowel disease [0.03%]
胃肠、骨骼和肌肉：炎症性肠病的骨肌减少症三联征
Shilpa Sharma
Shilpa Sharma
Inflammatory bowel disease (IBD) is a group of chronic inflammatory conditions affecting the gastrointestinal tract that can lead to multiple systemic complications. Among these, osteosarcopenia has emerged as a significant concern, charact...
Clinical characteristics of patients with difficult-to-treat ulcerative colitis: a nested case-control study using a Japanese claims database [0.03%]
难治性溃疡性结肠炎患者的临床特征：日本理赔数据库中的一项病例对照研究
Katsuyoshi Matsuoka,Ataru Igarashi,Noriko Sato et al.
Katsuyoshi Matsuoka et al.
Background/aims: Despite the advent of advanced therapies, cases of so-called "difficult-to-treat" (D2T) ulcerative colitis (UC) persist. This study aims to clarify the epidemiological and clinical characteristics of pati...
Efficacy and safety of etrasimod in Japanese patients with ulcerative colitis: results from a phase 2 dose-ranging study [0.03%]
艾替洛尔治疗日本溃疡性结肠炎患者的有效性和安全性：一项Ⅱ期剂量范围研究结果
Ken Takeuchi,Hiroshi Nakase,Tadakazu Hisamatsu et al.
Ken Takeuchi et al.
Background/aims: Etrasimod is an oral, once-daily, selective sphingosine 1-phosphate1,4,5 receptor modulator for the treatment of moderately to severely active ulcerative colitis (UC). However, its efficacy, safety, and t...
Inflammatory bowel disease in a young female patient with a novel de novo TRAF3 frameshift variant responsive to ustekinumab: a case report [0.03%]
年轻女性溃疡性结肠炎患者新发TRAF3移码变异病例的乌司奴单抗治疗响应研究报告
Ichiro Takeuchi,Kosuke Taniguchi,Katsuhiro Arai et al.
Ichiro Takeuchi et al.
Tumor necrosis factor receptor-associated factor 3 (TRAF3) is an anti-inflammatory molecule that negatively regulates the non-canonical nuclear factor-κB pathway. Although TRAF3 haploinsufficiency (TRAF3 HI) can influence innate and adapti...
Case Reports
Intestinal research. 2025 Apr 4. DOI:10.5217/ir.2024.00190 2025